Le Lézard
Classified in: Health
Subject: SVY

Molecular Diagnostics Market 2021: US, Europe, Japan--Sales and Market Shares by Product and Country


LONDON, Nov. 22, 2017 /PRNewswire/ --

This unique report from VPGMarketResearch.com provides sales and market share estimates for major suppliers of molecular diagnostic products by country.



Download the full report: https://www.reportbuyer.com/product/5208494

The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements, and business strategies.

Competitive Assessments

- Abbott
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- CellMark Forensics/LabCorp
- Cepheid
- Decode Genetics
- Diadexus
- Eiken
- Elitech Group
- Enzo
- Exact Sciences
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech
- Li-Cor Biosciences
- Monogram Biosciences/LabCorp
- Myriad Genetics
- Ortho-Clinical Diagnostics
- Perkin Elmer/Caliper
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher/Affymetrix

Partial List of Tables

- France
AIDS Testing Market
Estimated Sales by Major Supplier

France
Adenovirus Testing Market
Estimated Sales by Major Supplier

France
Chlamydia Testing Market
Estimated Sales by Major Supplier

France
CMV Testing Market
Estimated Sales by Major Supplier

France
Gonorrhea Testing Market
Estimated Sales by Major Supplier

France
Hepatitis Testing Market
Estimated Sales by Major Supplier

France
Hepatitis C Testing Market
Estimated Sales by Major Supplier

France
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier

France
Herpes Testing Market
Estimated Sales by Major Supplier

France
Influenza Testing Market
Estimated Sales by Major Supplier

France
Meningitis Testing Market
Estimated Sales by Major Supplier

France
Mycoplasma Testing Market
Estimated Sales by Major Supplier

France
RSV Testing Market
Estimated Sales by Major Supplier

France
Shigella Testing Market
Estimated Sales by Major Supplier

Germany
AIDS Testing Market
Estimated Sales by Major Supplier

Germany
CMV Testing Market
Estimated Sales by Major Supplier

Germany
EBV Testing Market
Estimated Sales by Major Supplier

Germany
Gonorrhea Testing Market
Estimated Sales by Major Supplier

Germany
Hepatitis Testing Market
Estimated Sales by Major Supplier

Germany
Hepatitis C Testing Market
Estimated Sales by Major Supplier

Germany
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier

Germany
Herpes Testing Market
Estimated Sales by Major Supplier

Germany
Influenza Testing Market
Estimated Sales by Major Supplier

Germany
Meningitis Testing Market
Estimated Sales by Major Supplier

Germany
Mycoplasma Testing Market
Estimated Sales by Major Supplier

Germany
Pneumonia Testing Market
Estimated Sales by Major Supplier

Germany
RSV Testing Market
Estimated Sales by Major Supplier

Germany
Rotavirus Testing Market
Estimated Sales by Major Supplier

Italy
AIDS Testing Market
Estimated Sales by Major Supplier

Italy
CMV Testing Market
Estimated Sales by Major Supplier

Italy
Gonorrhea Testing Market
Estimated Sales by Major Supplier

Italy
Hepatitis Testing Market
Estimated Sales by Major Supplier

Italy
Hepatitis C Testing Market
Estimated Sales by Major Supplier

Italy
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier

Italy
Herpes Testing Market
Estimated Sales by Major Supplier

Italy
Influenza Testing Market
Estimated Sales by Major Supplier

Italy
Meningitis Testing Market
Estimated Sales by Major Supplier

Italy
Mycoplasma Testing Market
Estimated Sales by Major Supplier

Italy
RSV Testing Market
Estimated Sales by Major Supplier

Japan
AIDS Testing Market
Estimated Sales by Major Supplier

Japan
Chlamydia Testing Market
Estimated Sales by Major Supplier

Japan
CMV Testing Market
Estimated Sales by Major Supplier

Japan
Gonorrhea Testing Market
Estimated Sales by Major Supplier

Japan
Hepatitis Testing Market
Estimated Sales by Major Supplier

Japan
Hepatitis C Testing Market
Estimated Sales by Major Supplier

Japan
Herpes Testing Market
Estimated Sales by Major Supplier

Japan
Meningitis Testing Market
Estimated Sales by Major Supplier

Japan
Mycoplasma Testing Market
Estimated Sales by Major Supplier

Japan
Pneumonia Testing Market
Estimated Sales by Major Supplier

Japan
Shigella Testing Market
Estimated Sales by Major Supplier

Spain
AIDS Testing Market
Estimated Sales by Major Supplier

Spain
Chlamydia Testing Market
Estimated Sales by Major Supplier

Spain
CMV Testing Market
Estimated Sales by Major Supplier

Spain
Gonorrhea Testing Market
Estimated Sales by Major Supplier

Spain
Hepatitis Testing Market
Estimated Sales by Major Supplier

Spain
Hepatitis C Testing Market
Estimated Sales by Major Supplier

Spain
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier

Spain
Herpes Testing Market
Estimated Sales by Major Supplier

Spain
Influenza Testing Market
Estimated Sales by Major Supplier

Spain
Meningitis Testing Market
Estimated Sales by Major Supplier

Spain
Mycoplasma Testing Market
Estimated Sales by Major Supplier

U.K.
AIDS Testing Market
Estimated Sales by Major Supplier

U.K.
Gonorrhea Testing Market
Estimated Sales by Major Supplier

U.K.
Hepatitis Testing Market
Estimated Sales by Major Supplier

U.K.
Hepatitis C Testing Market
Estimated Sales by Major Supplier

U.K.
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier

U.K.
Influenza Testing Market
Estimated Sales by Major Supplier

U.K.
Mycoplasma Testing Market
Estimated Sales by Major Supplier

Contains 211 pages and 91 tables


Download the full report: https://www.reportbuyer.com/product/5208494

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer


These press releases may also interest you

at 07:50
Peptide Synthesis Market Trends and Global Analysis Report 2024: Demand for GLP-1 Peptide API Contract Manufacturing has Increased Significantly - Forecasts to 2035 - ResearchAndMarkets.com
The "Peptide Synthesis Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Peptide Synthesis Method, Type of Chemical Synthesis, Contract Manufacturing Organization Size, Key Geographical Regions" report has been added to...

at 07:45
Global Laboratory Filtration Equipment Research Report 2023-2030 - Increase in Vaccine Production, Bioburden Control in a Booming Biopharmaceutical Industry Spurs Opportunities - ResearchAndMarkets.com
The "Laboratory Filtration Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Laboratory Filtration Equipment Market to Reach $3 Billion by 2030 The global market for Laboratory...

at 07:40
Global Weight Loss Drugs Markets Report 2023-2024 & 2029 - The Emergence of GLP-1 and GIP, Unmet Market Needs and Emerging Product Pipeline - ResearchAndMarkets.com
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...

at 07:35
Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule...

at 07:35
AbbVie Reports First-Quarter 2024 Financial Results
Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable Impact of $0.08 Per Share Related to Acquired IPR&D and...

at 07:30
INTEGRAcare Inc. has been named as #1 Best Workplace in Healthcare in Canada & the 5th Best Workplace in Canada (across all industries) in 2024 by Great Place to Work®
During an awards ceremony to present the 2024 list of Best Workplacestm in Canada, Great Place to Work® announced the 50 Best Workplacestm in Canada with 100-999 employees....

More news about Health...


News published on and distributed by: